Q1 carried $584 million in IPR&D charges plus $279 million in litigation and restructuring
Yes, Sembolic medicine can support weight loss in patients with Diabetes by reducing appetite, slowing stomach emptying, and improving blood sugar control
At the same time, pharmaceutical companies have faced increasing public and regulatory pressure to lower self-pay (cash) prices for these medications though pricing and discount programs vary by drug and pharmacy
This service has become especially important due to frequent shortages of GLP-1 medications, including well-known brands like Wegovy, Ozempic, and Rybelsus
Never share human cardiac medications with your dog, as the formulations, doses, and safety profiles are not interchangeable